rs201278114
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Postmortem genetic screening for the identification, verification, and reporting of genetic variants contributing to the sudden death of the young.
|
27435932 |
2016 |
rs10500279
|
|
|
0.700 |
GeneticVariation |
GWASDB |
Common variants in RYR1 are associated with left ventricular hypertrophy assessed by electrocardiogram.
|
21828061 |
2012 |
rs2071090
|
|
|
0.700 |
GeneticVariation |
GWASDB |
Common variants in RYR1 are associated with left ventricular hypertrophy assessed by electrocardiogram.
|
21828061 |
2012 |
rs2960321
|
|
|
0.700 |
GeneticVariation |
GWASDB |
Common variants in RYR1 are associated with left ventricular hypertrophy assessed by electrocardiogram.
|
21828061 |
2012 |
rs1436109
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families.
|
21212386 |
2011 |
rs121908596
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
|
18042262 |
2008 |
rs1060501439
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397516037
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs768079285
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs869312687
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Angiotensinogen M235T and T174M polymorphisms have individually been associated with elevated levels of plasma angiotensinogen, hypertension, and left ventricular hypertrophy.
|
17145981 |
2007 |
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Polymorphism of the AGT M235T gene but not ACE I/D gene is associated with greater LVMi and relative wall thickness, indicating more concentric LVH, in Chinese peritoneal dialysis patients.
|
12675870 |
2003 |
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
The angiotensinogen T174M and M235T and the AT1-receptor A1166C polymorphisms were related to the change in LVH during antihypertensive treatment with an AT1-receptor antagonist; of these angiotensinogen T174M was the most powerful.
|
11910301 |
2002 |
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
These results suggest an association of combined angiotensin I-converting enzyme gene I/D polymorphism genotypes, and angiotensinogen gene M235T polymorphism genotypes with left ventricular hypertrophy due to long-term athletic training.
|
11737220 |
2001 |
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
There are controversies concerning the association of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism with left ventricular hypertrophy (LVH), and the unclear association between angiotensinogen (ATG) M235T polymorphism and LVH.
|
10646957 |
2000 |
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Angiotensinogen gene M235T polymorphism is associated with the variability in left ventricular hypertrophy induced by endurance training, with athletes homozygous for the T allele having the largest hearts.
|
10440164 |
1999 |
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Polymorphism of the AGT M235T gene but not ACE I/D gene is associated with greater LVMi and relative wall thickness, indicating more concentric LVH, in Chinese peritoneal dialysis patients.
|
12675870 |
2003 |
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
The angiotensinogen T174M and M235T and the AT1-receptor A1166C polymorphisms were related to the change in LVH during antihypertensive treatment with an AT1-receptor antagonist; of these angiotensinogen T174M was the most powerful.
|
11910301 |
2002 |
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
These results suggest an association of combined angiotensin I-converting enzyme gene I/D polymorphism genotypes, and angiotensinogen gene M235T polymorphism genotypes with left ventricular hypertrophy due to long-term athletic training.
|
11737220 |
2001 |
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
There are controversies concerning the association of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism with left ventricular hypertrophy (LVH), and the unclear association between angiotensinogen (ATG) M235T polymorphism and LVH.
|
10646957 |
2000 |
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Angiotensinogen gene M235T polymorphism is associated with the variability in left ventricular hypertrophy induced by endurance training, with athletes homozygous for the T allele having the largest hearts.
|
10440164 |
1999 |
rs397516005
|
|
|
0.040 |
GeneticVariation |
BEFREE |
We studied 140 carriers (G+) of the TPM1-Asp175Asn or MYBPC3-Gln1061X pathogenic variants for HCM: The G+/LVH+ group (n = 98) consisted of mutation carriers with LVH and the G+/LVH- group (n = 42) without LVH.
|
30497761 |
2019 |
rs397516005
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Septal convexity was significantly increased in subjects with the MYBPC3-Q1061X mutation and LVH (n = 32) compared to controls (11.4 ± 4.3 vs 2.7 ± 3.2 mm, P < 0.001).
|
30976029 |
2019 |
rs397516005
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Our objective was to measure the length of mitral valve leaflets by cardiovascular magnetic resonance (CMR) in subjects with HCM caused by a Finnish founder mutation in the myosin-binding protein C gene (MYBPC3-Q1061X), carriers of the same mutation without left ventricular hypertrophy, as well as in unselected consecutive patients with HCM, and respective controls.
|
27259862 |
2016 |
rs397516005
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Concentrations of branched chain amino acids, triglycerides and ether phospholipids were increased in mutation carriers with hypertrophy as compared to controls and non-hypertrophic mutation carriers, and correlated with echocardiographic LVH and signs of diastolic and systolic dysfunction in subjects with the MYBPC3-Q1061X mutation.
|
26267065 |
2015 |